The pharmaceutical industry is rapidly expanding to meet the global demand for innovative drug products, resulting in regulatory complexity. To adapt to this complexity, both vendors and sponsors are implementing new technology to augment the regulatory workflow, including automation and artificial intelligence (AI). The evolution of regulatory technology and management has seen a shift from paper-based processes to advanced registration tracking and structured data submissions. Emerging trends in the space include increased outsourcing and reliance on business engagement and the availability of high-quality data to drive intelligent applications and solutions.

Read this white paper to learn more about using technology to augment regulatory affairs.